K
Kardium
Health Tech & Medtech · Burnaby, Canada · Founded 2007
Develops medical devices for the diagnosis and treatment of atrial fibrillation MoreLess
Kardium is a medical device company specializing in the treatment of atrial fibrillation, a common heart rhythm disorder affecting over 37 million people globally. The company's core product, the Globe System, integrates high-definition anatomical and electrical mapping with radio frequency energy delivery to isolate pulmonary veins and ablate atrial tissue. This comprehensive solution is designed for cardiologists and electrophysiologists, offering a single device for multiple procedures. Kardium operates in the medical technology market, primarily targeting healthcare providers and institutions. The business model revolves around the sale of its advanced catheter systems and related services, generating revenue through direct sales and long-term contracts with medical facilities. The company is headquartered in greater Vancouver, Canada, and boasts a team of experts in medicine, engineering, and business.
Keywords: atrial fibrillation, catheter system, high-definition mapping, radio frequency ablation, pulmonary vein isolation, electrophysiology, cardiology, medical device, healthcare technology, Vancouver.
Company overview
Kardium company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2007
- Headquarters
- Burnaby, Canada
- Employees
- 636
- Open positions
- 60
- Dealroom signal
- 96.0
Valuation & funding
Kardium funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2025 | $250M | $1B | T. Rowe Price · Durable Capital Partners · Qatar Investment Authority · Eventide Asset Management | ↗ |
| LATE VCOther financing | Jun 2024 | $104M | $416M | T. Rowe Price · Durable Capital Partners · Fidelity Investments | ↗ |
| GRANTOther financing | Mar 2022 | $3.7M | — | PacifiCan | — |
| GROWTH EQUITY VCOther financing | Jan 2021 | $115M | — | Fidelity Investments · T. Rowe Price | ↗ |
| GROWTH EQUITY VCOther financing | Feb 2019 | — | — | T. Rowe Price | — |
| LATE VCOther financing | Apr 2015 | Conconi Growth Partners | — | ||
| SERIES DOther financing | Apr 2014 | Conconi Growth Partners | — | ||
| GRANTOther financing | Sep 2013 | National Research Council Canada | — | ||
| EARLY VCOther financing | Aug 2010 | Undisclosed | — | ||
| SPINOUTOther financing | Jan 2007 | The University of British Columbia | — |
Growth signals
Kardium website traffic
Latest recorded traffic for Kardium is 16K monthly website visits, up 0% over the last three months. Kardium's team grew 29.8% over the past year.
Hiring
Open positions at Kardium
Current openings linked to this company in Dealroom.
Comparisons
Kardium compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Kardium's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Kardium has talent and traffic
team presence
In the news
Latest news about Kardium
Recent press, funding announcements, and product moves mentioning Kardium — open to read from the original sources.
Market sentiment
What the market is saying about Kardium
An AI-synthesized read of the highest-engagement posts about Kardium on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kardium’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.